Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9) Peptide
Quick Overview for Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9) Peptide (ABIN937425)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- DLDTWQENTN AWEEEEDAAW QAEEVLRQQK LADREKRAAE QQRKKMEKEA
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of EBAG9 antibody,
Alternative Names: EBAG9 control peptide, EBAG9 antibody Blocking Peptide, Anti-EBAG9 Blocking Peptide, estrogen receptor binding site associated, antigen, 9 Blocking Peptide, EB9 Blocking Peptide, PDAF Blocking Peptide, RCAS1 Blocking Peptide, EBAG9, EBAG-9, EBAG 9, EBAG-9 Blocking Peptide, EBAG 9 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))
-
Background
- This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Two transcript variants differing in the 5' UTR, but encoding the same protein, have been identified for this gene.
-
Molecular Weight
- 24 kDa
Target
-